Jaguar Animal Health, Inc. (JAGX) vs Jupiter Neurosciences, Inc. (JUNS)

Jaguar Animal Health, Inc. and Jupiter Neurosciences, Inc. are both Biotechnology companies. Jaguar Animal Health, Inc. and Jupiter Neurosciences, Inc. are of similar size ($3.8M and $3.8M). Jupiter Neurosciences, Inc. has negative trailing earnings, so its P/E is not meaningful; Jaguar Animal Health, Inc. trades at 0.1×. Jupiter Neurosciences, Inc. has the higher net margin (0.00% vs −188.5%) and the higher return on invested capital (0.00% vs −28,393.6%). Across the 12 metrics below, Jaguar Animal Health, Inc. leads on 7 and Jupiter Neurosciences, Inc. on 5.

Valuation

Metric JAGX JUNS Biotechnology median
P/E 0.06 n/m 7.88
P/S 0.22 n/m 11.47
P/B 1.27 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 0.19 n/m 10.73
Earnings yield 1,566.54% (716.02%) (28.84%)
Free cash flow yield (118.33%) (486.93%) (23.03%)

Profitability

Metric JAGX JUNS Biotechnology median
Gross margin 82.31% — 65.16%
Operating margin (93.10%) 0.00% 0.00%
Net margin (188.46%) 0.00% 0.00%
Free cash flow margin (24.03%) 0.00% 0.00%
Return on equity (1,125.38%) (1,888.80%) (57.72%)
Return on assets (127.14%) (239.36%) (49.22%)
Return on invested capital (28,393.64%) 0.00% 0.00%

Growth

Metric JAGX JUNS Biotechnology median
Revenue growth (TTM) 135.52% — 5.64%
EPS growth (last fiscal year) 82.42% (212.50%) —
Revenue growth, 5-year CAGR 4.17% — 8.40%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric JAGX JUNS Biotechnology median
Debt to equity 0.35 0.00 0.00
Current ratio 0.69 0.66 4.73
Net debt to EBITDA (0.17) 0.43 0.96

Dividend

Metric JAGX JUNS Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric JAGX JUNS Biotechnology median
Market cap 3.80m 3.80m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack